Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Axsome Therapeutics, Inc. market cap for the quarter ending 2026-08-03 was $11.06B, a 120.79% increase year-over-year.
Axsome Therapeutics, Inc. market cap for the quarter ending 2026-06-30 was $12.81B, a 146.29% increase year-over-year.
Axsome Therapeutics, Inc. market cap for the quarter ending 2026-04-27 was $9.64B, a 82.50% increase year-over-year.
Axsome Therapeutics, Inc. market cap for the quarter ending 2026-03-31 was $8.68B, a 51.30% increase year-over-year.
Axsome Therapeutics, Inc. market cap for fiscal 2026 was $11.06B.
Axsome Therapeutics, Inc. market cap for fiscal 2025 was $9.3B, a 125.80% increase from fiscal 2024.
Axsome Therapeutics, Inc. market cap for fiscal 2024 was $4.12B, a 9.26% increase from fiscal 2023.
Axsome Therapeutics, Inc. market cap for fiscal 2023 was $3.77B, a 12.33% increase from fiscal 2022.